Trial NCT01921751

View at ClinicalTrials.gov 
Org. Study IDs: RTOG 1201
Secondary IDs: NCI-2013-01280 RTOG 1201 RTOG-1201 U10CA021661 U10CA180868

Last trial update was posted on 2018-07-13

MeSH Interventions

Albumin-Bound Paclitaxel Capecitabine Gemcitabine Paclitaxel

MeSH Conditions

Pancreatic Neoplasms

Other Conditions

Pancreatic Adenocarcinoma Stage III Pancreatic Cancer

Stopping Reasons

Trial would not be completed in a reasonable timeframe per CTEP guidelines

Limitations And Caveats

This study terminated early with only 20 registered (346 planned) and 13 randomized (288 planned). Follow-up forms were collected on only 3 patients.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID